41
Participants
Start Date
May 15, 2023
Primary Completion Date
November 21, 2023
Study Completion Date
January 17, 2024
BRII-297
Escalating doses of BRII-297 will be given in different cohorts i.e., Cohorts 1 through 6
Placebo
Escalating doses of placebo will be given in different cohorts i.e., Cohorts 1 through 6
CMAX, Adelaide
Lead Sponsor
Brii Biosciences Limited
INDUSTRY